ERBB2 and breast cancer: In HER2+ BC cells SKBR3 and BT474, THZ1 not only inhibited a set of genes that were downregulated by lapatinib (Supplementary Fig. S3c), but also suppressed the expression of a large number of genes that were upregulated by lapatinib.